PMDA — authorised 27 September 2021
- Marketing authorisation holder: OHARA PHARMACEUTICAL CO., LTD
- Status: approved
🇯🇵 Voraxaze in Japan
PMDA authorised Voraxaze on 27 September 2021
Marketing authorisation
Voraxaze in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in Japan
Frequently asked questions
Is Voraxaze approved in Japan?
Yes. PMDA authorised it on 27 September 2021.
Who is the marketing authorisation holder for Voraxaze in Japan?
OHARA PHARMACEUTICAL CO., LTD holds the Japanese marketing authorisation.